Maynard Um
-
-
-
-
-
-
-
Internet Patents (PTNT) vPresents Promising Preclinical Data on Melanocortin Agonists for Retinopathy
-
-
-
-
-
-
-
Palatin Technologies (PTN) Appeals NYSE American Notice of Delisting
-
-
-
-
-
-
-
Palatin Technologies (PTN) Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement
-
-
-
-
-
-
-
Palatin Technologies (PTN) Files for 4.85M Share Offering by Selling Stockholders
-
-
-
-
-
-
-
Palatin Technologies (PTN): First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

